Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Study evaluating effect of switching from twice-daily to once-daily Tacrolimus on renal function and diabetic parameters in stable lung transplant recipients

Trial Profile

Study evaluating effect of switching from twice-daily to once-daily Tacrolimus on renal function and diabetic parameters in stable lung transplant recipients

Completed
Phase of Trial: Phase IV

Latest Information Update: 25 Apr 2018

At a glance

  • Drugs Tacrolimus (Primary)
  • Indications Transplant rejection
  • Focus Pharmacodynamics; Pharmacokinetics
  • Most Recent Events

    • 25 Apr 2018 New trial record
    • 14 Apr 2018 Results presented at the 38th Annual Meeting and Scientific Sessions of the International Society for Heart and Lung Transplantation
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top